Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Proceedings of the National Academy of Sciences of the United States of America
|
October 9, 2013
Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia
Joanna Baginska, Elodie Viry, Guy Berchem, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 29, 2017
Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner
Takouhie Mgrditchian, Tsolere Arakelian, Jérôme Paggetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 7, 2009
The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis
Muhammad Zaeem Noman, Stéphanie Buart, Jos Van Pelt, et al.
Nature Communications
|
May 16, 2022
Mitochondria preserve an autarkic one-carbon cycle to confer growth-independent cancer cell migration and metastasis
Nicole Kiweler, Catherine Delbrouck, Vitaly I Pozdeev, et al.
Cancer Research
|
February 26, 2013
Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis
Intissar Akalay, Bassam Janji, Meriem Hasmim, et al.
Cancer Research
|
October 10, 2014
ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy
Yosra Messai, Muhammad Zaeem Noman, Meriem Hasmim, et al.
European Urology
|
December 29, 2015
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status
Yosra Messai, Sophie Gad, Muhammad Zaeem Noman, et al.
The Journal of Experimental Medicine
|
April 13, 2011
A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor
Sophie Chabot, Nabila Jabrane-Ferrat, Karine Bigot, et al.
Molecular Oncology
|
March 20, 2024
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Proceedings of the National Academy of Sciences of the United States of America
|
October 9, 2013
Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia
Joanna Baginska, Elodie Viry, Guy Berchem, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 29, 2017
Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner
Takouhie Mgrditchian, Tsolere Arakelian, Jérôme Paggetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 7, 2009
The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis
Muhammad Zaeem Noman, Stéphanie Buart, Jos Van Pelt, et al.
Nature Communications
|
May 16, 2022
Mitochondria preserve an autarkic one-carbon cycle to confer growth-independent cancer cell migration and metastasis
Nicole Kiweler, Catherine Delbrouck, Vitaly I Pozdeev, et al.
Cancer Research
|
February 26, 2013
Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis
Intissar Akalay, Bassam Janji, Meriem Hasmim, et al.
Cancer Research
|
October 10, 2014
ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy
Yosra Messai, Muhammad Zaeem Noman, Meriem Hasmim, et al.
European Urology
|
December 29, 2015
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status
Yosra Messai, Sophie Gad, Muhammad Zaeem Noman, et al.
The Journal of Experimental Medicine
|
April 13, 2011
A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor
Sophie Chabot, Nabila Jabrane-Ferrat, Karine Bigot, et al.
Molecular Oncology
|
March 20, 2024
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, et al.
Page
of 6